Abstract
The worldwide prevalence of obesity is increasing, raising health concerns regarding obesity-related complications. Chronic inflammation has been characterized as a major contributor to the development of obesity and obesity-associated metabolic disorders. The purpose of the current study is to assess whether the overexpression of interferon beta (IFNβ1), an immune-modulating cytokine, will attenuate high-fat diet-induced adipose inflammation and protect animals against obesity development. Using hydrodynamic gene transfer to elevate and sustain blood concentration of IFNβ1 in mice fed a high-fat diet, we showed that the overexpression of Ifnβ1 gene markedly suppressed immune cell infiltration into adipose tissue, and attenuated production of pro-inflammatory cytokines. Systemically, IFNβ1 blocked adipose tissue expansion and body weight gain, independent of food intake. Possible browning of white adipose tissue might also contribute to blockade of weight gain. More importantly, IFNβ1 improved insulin sensitivity and glucose homeostasis. These results suggest that targeting inflammation represents a practical strategy to block the development of obesity and its related pathologies. In addition, IFNβ1-based therapies have promising potential for clinical applications for the prevention and treatment of various inflammation-driven pathologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kanneganti TD, Dixit VD . Immunological complications of obesity. Nat Immunol 2012; 13: 707–712.
Monteiro R, Azevedo I . Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm, e-pub ahead of print 14 July 2010 doi:10.1155/2010/289645.
Donath MY, Dalmas É, Sauter NS, Böni-Schnetzler M . Inflammation in obesity and diabetes: islet dysfunction and dherapeutic dpportunity. Cell Metab 2013; 17: 860–872.
Parmar S, Platanias LC . Interferons: mechanisms of action and clinical applications. Curr Opin Oncol 2003; 15: 431–439.
Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 1996; 39: 285–294.
Kieseier BC . The mechanism of action of interferon-beta in relapsing multiple sclerosis. CNS Drugs 2011; 25: 491–502.
Hotamisligil GS, Shargill NS, Spiegelman BM . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.
Kahn SE, Hull RL, Utzschneider KM . Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840–846.
Ye J . Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes 2009; 33: 54–66.
Ye J, Gao Z, Yin J, He Q . Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293: E1118–E11128.
Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901–911.
Mannon PJ, Hornung RL, Yang Z, Yi C, Groden C, Friend J et al. Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production. Gut 2011; 60: 449–455.
Yoshimura A . Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 2006; 97: 439–447.
Wang H, Brown J, Garcia CA, Tang Y, Benakanakere MR, Greenway T et al. The role of glycogen synthase kinase 3 in regulating IFN-beta-mediated IL-10 production. J Immunol 2011; 186: 675–684.
Asadullah K, Sterry W, Volk HD . Interleukin-10 therapy—review of a new approach. Pharmacol Rev 2003; 55: 241–269.
Shoelson SE, Lee J, Yuan M . Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003; 27 (Suppl 3): S49–S52.
Boscá L, Bodelón OG, Hortelano S, Casellas A, Bosch F . Anti-inflammatory action of type I interferons deduced from mice expressing interferon beta. Gene Therapy 2000; 7: 817–825.
Pang C, Gao Z, Yin J, Zhang J, Jia W, Ye J . Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab 2008; 295: E313–E322.
Christiaens V, Lijnen HR . Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 2010; 318: 2–9.
Dridi S, Taouis M . Adiponectin and energy homeostasis: consensus and controversy. J Nutr Biochem 2009; 20: 831–839.
Shoelson SE, Lee J, Goldfine AB . Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793–1801.
Yadav A, Kataria MA, Saini V, Yadav A . Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 2013; 417: 80–84.
Burke JD, Platanias LC, Fish EN . Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3. J Virol 2014; 88: 3485–3495.
Liu F, Song Y, Liu D . Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258–1266.
Zhang G, Budker V, Wolff JA . High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Therapy 1999; 10: 1735–1737.
Acknowledgements
We thank Dr. Megan Morgan for proofreading the manuscript. The study was supported in part by grant from NIH (RO1HL098295).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Gene Therapy website
Supplementary information
Rights and permissions
About this article
Cite this article
Alsaggar, M., Mills, M. & Liu, D. Interferon beta overexpression attenuates adipose tissue inflammation and high-fat diet-induced obesity and maintains glucose homeostasis. Gene Ther 24, 60–66 (2017). https://doi.org/10.1038/gt.2016.76
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2016.76
This article is cited by
-
Mitochondrial RNA stimulates beige adipocyte development in young mice
Nature Metabolism (2022)
-
Type I interferon sensing unlocks dormant adipocyte inflammatory potential
Nature Communications (2020)
-
South Asian men have lower expression of IFN signalling genes in white adipose tissue and skeletal muscle compared with white men
Diabetologia (2017)